Horacio Ruiseñor-Escudero1, Itziar Familiar-Lopez, Alla Sikorskii, Nikita Jambulingam, Noelline Nakasujja, Robert Opoka, Judith Bass, Michael Boivin. 1. *Department of Psychiatry, Michigan State University, East Lansing, MI; †Department of Statistics and Probability, Michigan State University, East Lansing, MI; ‡University of Michigan Medical School, Ann Arbor, MI; §Department of Psychiatry, College of Health Sciences, Makerere University, Kampala, Uganda; ‖Department of Pediatrics and Child Health, College of Health Sciences, Makerere University, Kampala, Uganda; and ¶Mental Health Department, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Abstract
OBJECTIVE: To identify the nutritional and immunological correlates of memory and neurocognitive development as measured by the Mullen Scales of Early Learning (MSEL) and by the Color Object Association Test (COAT) among children in Uganda. DESIGN: This analysis uses baseline data collected between 2008 and 2010 from 119 HIV-infected children aged 1-6 years, participating in a randomized controlled trial of an interventional parenting program in Kayunga, Uganda. METHODS: Peripheral blood draws were performed to determine immunological biomarkers. Unadjusted and adjusted linear regression models were used to relate MSEL and COAT scores to sociodemographic characteristics, weight-for-age Z scores (WAZs), antiretroviral therapy status, and immunological biomarkers. RESULTS: In the final analysis, 111 children were included. Lower levels of CD4 CD38 T cells (P = 0.04) were associated to higher immediate and total recall scores (P = 0.04). Higher levels of CD8 HLA-DR T cells were associated with higher total recall score (P = 0.04) of the COAT. Higher CD4 CD38 HLA-DR T cells levels were associated with higher gross motor scores of the MSEL (P = 0.02). WAZ was positively correlated to visual reception, fine motor, expressive language, and composite score of the MSEL. CONCLUSIONS: Overall, WAZ was a stronger predictor of neurocognitive outcomes assessed by the MSEL. CD4 CD38 T cells were more specifically associated with memory-related outcomes. Future research should include immunological markers and standardized neurocognitive tests to further understand this relationship.
OBJECTIVE: To identify the nutritional and immunological correlates of memory and neurocognitive development as measured by the Mullen Scales of Early Learning (MSEL) and by the Color Object Association Test (COAT) among children in Uganda. DESIGN: This analysis uses baseline data collected between 2008 and 2010 from 119 HIV-infectedchildren aged 1-6 years, participating in a randomized controlled trial of an interventional parenting program in Kayunga, Uganda. METHODS: Peripheral blood draws were performed to determine immunological biomarkers. Unadjusted and adjusted linear regression models were used to relate MSEL and COAT scores to sociodemographic characteristics, weight-for-age Z scores (WAZs), antiretroviral therapy status, and immunological biomarkers. RESULTS: In the final analysis, 111 children were included. Lower levels of CD4CD38 T cells (P = 0.04) were associated to higher immediate and total recall scores (P = 0.04). Higher levels of CD8 HLA-DR T cells were associated with higher total recall score (P = 0.04) of the COAT. Higher CD4CD38 HLA-DR T cells levels were associated with higher gross motor scores of the MSEL (P = 0.02). WAZ was positively correlated to visual reception, fine motor, expressive language, and composite score of the MSEL. CONCLUSIONS: Overall, WAZ was a stronger predictor of neurocognitive outcomes assessed by the MSEL. CD4CD38 T cells were more specifically associated with memory-related outcomes. Future research should include immunological markers and standardized neurocognitive tests to further understand this relationship.
Authors: D Drotar; K Olness; M Wiznitzer; L Guay; L Marum; G Svilar; D Hom; J F Fagan; C Ndugwa; R Kiziri-Mayengo Journal: Pediatrics Date: 1997-07 Impact factor: 7.124
Authors: Heena Brahmbhatt; Michael Boivin; Victor Ssempijja; Godfrey Kigozi; Joseph Kagaayi; David Serwadda; Ronald H Gray Journal: J Acquir Immune Defic Syndr Date: 2014-11-01 Impact factor: 3.731
Authors: Rita J Jeremy; Soyeon Kim; Molly Nozyce; Sharon Nachman; Kenneth McIntosh; Stephen I Pelton; Ram Yogev; Andrew Wiznia; George M Johnson; Paul Krogstad; Kenneth Stanley Journal: Pediatrics Date: 2005-02 Impact factor: 7.124
Authors: Silvia Sánchez-Ramón; José Ma Bellón; Salvador Resino; Carmen Cantó-Nogués; Dolores Gurbindo; José-Tomás Ramos; Ma Angeles Muñoz-Fernández Journal: Pediatrics Date: 2003-02 Impact factor: 7.124
Authors: M H Ultmann; G W Diamond; H A Ruff; A L Belman; B E Novick; A Rubinstein; H J Cohen Journal: Int J Neurosci Date: 1987-02 Impact factor: 2.292
Authors: Itziar Familiar; Shalean M Collins; Alla Sikorskii; Horacio Ruisenor-Escudero; Barnabas Natamba; Paul Bangirana; Elizabeth M Widen; Daniel Achidri; Harriet Achola; Daniel Onen; Michael Boivin; Sera L Young Journal: J Acquir Immune Defic Syndr Date: 2018-03-01 Impact factor: 3.731